共 50 条
- [1] ProPSA improves prostate cancer detection and tumor aggressiveness in PSA range 2.0-3.9 ng/ml [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 439 - 439
- [2] Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml:: Value of percent free prostate specific antigen on tumor detection and tumor aggressiveness [J]. JOURNAL OF UROLOGY, 2004, 171 (06): : 2245 - 2249
- [3] A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range [J]. JOURNAL OF UROLOGY, 2011, 185 (05): : 1650 - 1655
- [4] VALUE OF PROSTATE SPECIFIC ANTIGEN (PSA) MASS RATIO IN THE DETECTION OF PROSTATE CANCER IN MEN WITH PSA ≤ 10 NG/ML [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E895 - E895
- [5] A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range (vol 185, pg 1650, 2011) [J]. JOURNAL OF UROLOGY, 2011, 186 (01): : 354 - 355
- [7] Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 478 - 479
- [8] Verification bias in the assessment of prostate specific antigen (PSA) as a screening test for prostate cancer [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 474 - 474